| Thrombosis prevention and anticoagulation management in the pediatric patient with congenital heart disease E Abdelghani, CL Cua, J Giver, V Rodriguez Cardiology and Therapy 10, 325-348, 2021 | 9 | 2021 |
| Exploring the role of antithrombin in nephrotic syndrome–associated hypercoagulopathy: a multi-cohort study and meta-analysis E Abdelghani, AP Waller, KJ Wolfgang, JR Stanek, SV Parikh, BH Rovin, ... Clinical Journal of the American Society of Nephrology 18 (2), 234-244, 2023 | 4 | 2023 |
| CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience E Abdelghani, KM Schieffer, CE Cottrell, A Audino, K Zajo, N Shah Cancers 15 (6), 1649, 2023 | 2 | 2023 |
| Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome E Abdelghani, C Mueller, H Liu Cytometry. Part B, Clinical Cytometry 102 (5), 409-411, 2022 | 1 | 2022 |
| Fibrinogen Columbus III: A novel c. 963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype. E Abdelghani, J Dawson, K Zajo, M Hallam, A Dunn, R Kumar Pediatric Blood & Cancer 68 (3), e28713-e28713, 2020 | 1 | 2020 |
| Increasing optimal coagulation factor dosing in the paediatric emergency department: Update to a quality improvement study NE Kendel, E Abdelghani, JR Stanek, B Mitchell, MW Dunn, V Rodriguez, ... Haemophilia 30 (2), 367-374, 2024 | | 2024 |
| Pediatric arterial thrombosis: A single‐institution cohort study of patient characteristics and thrombosis outcomes E Abdelghani, S Agarwal, J Stanek, A Sankar, BA Kerlin, V Rodriguez Pediatric Blood & Cancer 71 (1), e30756, 2024 | | 2024 |
| Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes S Agarwal, E Abdelghani, JR Stanek, A Sankar, CL Cua, BA Kerlin, ... Research and Practice in Thrombosis and Haemostasis 7 (8), 102266, 2023 | | 2023 |
| OC 67.4 Intracardiac Thrombosis in Pediatrics: Anticoagulation Approach and Treatment Outcomes S Agarwal, E Abdelghani, J Stanek, C Cua, B Kerlin, V Rodriguez Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| OC 09.3 Direct Oral Anticoagulants Improve Podocyte Health and Reverse Hypercoagulopathy in an Experimental Model of Glomerular Disease E Abdelghani, A Waller, K Wolfgang, B Kerlin Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| PB0044 Pediatric Arterial Thrombosis: Patient Characteristics and Thrombosis Outcomes E Abdelghani, S Agarwal, J Stanek, A Sanker, V Rodriguez Research and Practice in Thrombosis and Haemostasis 7, 100718, 2023 | | 2023 |
| Prothrombin Knockdown Protects Podocytes and Reduces Proteinuria in Glomerular Disease AP Waller, KJ Wolfgang, I Pruner, ZS Stevenson, E Abdelghani, ... bioRxiv, 2023.06. 20.544360, 2023 | | 2023 |
| Limited Role of Antithrombin Deficiency in Nephrotic Syndrome-Associated Hypercoagulopathy E Abdelghani, AP Waller, KJ Wolfgang, JR Stanek, SV Parikh, BH Rovin, ... medRxiv, 2022.06. 24.22276257, 2022 | | 2022 |
| Limited Role of Antithrombin Deficiency in Hypercoagulopathy Associated with Nephrotic Syndrome E Abdelghani, AP Waller, KJ Wolfgang, BA Kerlin Blood 138 (Supplement 1), 294-294, 2021 | | 2021 |
| A Novel Assay Using Enzyme Capture-ELISA for Accurate Determination of Factor XIII Activity AP Waller, MA Durda, K Franz, E Abdelghani, BA Kerlin Blood 136, 23-24, 2020 | | 2020 |
